AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Pharmacokinetics

A Phase I Study of ABSK211 in Participants With Advanced Solid Tumors With KRAS Alteration NCT07718165Phase 11 site๐Ÿ“ Shanghai Abbisko Therapeutics Co, Ltd ยท Tests: ABSK211 Liposomal Bupivacaine Versus Plain Bupivacaine After Intercostal Injections For Pain Management After Thoracoscopy NCT03737292Phase 41 site๐Ÿ“ Hershey Milton S. Hershey Medical Center ยท Tests: Exparel, Bupivacaine A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors NCT07414836Phase 118 sites๐Ÿ“ Boston๐Ÿ“ St Louis๐Ÿ“ Hackensack BeOne Medicines ยท Tests: BG-C0979, Tislelizumab A Pharmacokinetics and Safety Study of Azvudine Tablets in Subjects With Mild-To-Moderate GFR Decline in Renal Insufficiency and in Healthy Subjects NCT07001436Phase 11 site๐Ÿ“ Beijing Henan Genuine Biotech Co., Ltd. ยท Tests: Azvudine tablets Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment NCT05661461Phase 12 sites๐Ÿ“ San Antonio๐Ÿ“ West Valley City Aadi Bioscience, Inc. ยท Tests: nab-sirolimus A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma๏ผˆKeyplus-001๏ผ‰ NCT05357651Phase 11 site๐Ÿ“ Shanghai L & L Bio Co., Ltd., Ningbo, China ยท Tests: LB1410 Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis NCT07809867Phase 41 site๐Ÿ“ Genova Istituto Giannina Gaslini ยท Tests: Elexacaftor, Tezacaftor, Ivacaftor, Ivacaftor (VX-770) A Study of BL-M05D1 in Patients With Locally Advanced or Metastatic Solid Tumors NCT06349811Phase 11 site๐Ÿ“ Beijing Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: BL-M05D1 An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors NCT07222267Phase 132 sites๐Ÿ“ Birmingham๐Ÿ“ New Haven๐Ÿ“ St Louis BeOne Medicines ยท Tests: BG-75202, CDK4 Inhibitor, Estrogen Receptor Antagonist, Aromatase Inhibitor A Clinical Study of HRS-7156 in Healthy Participants NCT07601087Phase 11 site๐Ÿ“ Shanghai Shandong Suncadia Medicine Co., Ltd. ยท Tests: HRS-7156, HRS-7156 placebo A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A. NCT07140614Phase 14 sites๐Ÿ“ Ottawa๐Ÿ“ Montreal๐Ÿ“ Montreal Novartis Pharmaceuticals ยท Tests: EDK060, dose A, EDK060, dose B, EDK060, dose C, EDK060, dose D, Placebo MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors NCT06912152Phase 11 site๐Ÿ“ Hangzhou Zhejiang University ยท Tests: MT027 CAR-T cells Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors NCT04557449Phase 1, Phase 239 sites๐Ÿ“ Los Angeles๐Ÿ“ New Haven๐Ÿ“ New Haven Pfizer ยท Tests: PF-07220060, Letrozole, Fulvestrant, Midazolam, Enzalutamide A Phase I Study of HS-20108 in Participants With Advanced Solid Tumors NCT06936735Phase 11 site๐Ÿ“ Shanghai Hansoh BioMedical R&D Company ยท Tests: HS-20108 Monotherapy Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection NCT05620017Phase 12 sites๐Ÿ“ Chongqing๐Ÿ“ Hangzhou Bio-Thera Solutions ยท Tests: BAT8008 for Injection Safety and Pharmacokinetics of ALZ-507 in Healthy Elderly Adults NCT07824271Phase 11 site๐Ÿ“ Miami Alzheon Inc. ยท Tests: ALZ-507, Placebo A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors NCT06716138Phase 15 sites๐Ÿ“ New York๐Ÿ“ Fuzhou๐Ÿ“ Guangzhou Avistone Biotechnology Co., Ltd. ยท Tests: ANS03 Assessment of [18F]-Fluorocellobiose ([18F]FCB) Pharmacokinetics in Healthy Volunteers and Subjects With Invasive Mold Infections NCT07704333Phase 11 site๐Ÿ“ Bethesda National Institutes of Health Clinical Center (CC) ยท Tests: [18F]-Fluorocellobiose ([18F]FCB) A Two-Part Single and Multiple Ascending Dose Trial of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LBT-3627 in Healthy Participants and in Participants With Parkinson's Disease. NCT06466525Phase 13 sites๐Ÿ“ Melbourne๐Ÿ“ Melbourne๐Ÿ“ Melbourne Longevity Biotech Australia Pty Ltd (subsidiary) ยท Tests: LBT-3627, Placebo A Study of GNC-077 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors NCT06609187Phase 11 site๐Ÿ“ Beijing Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: GNC-077 A Study of JMT203 in Patients With Cancer Cachexia NCT06868849Phase 1, Phase 21 site๐Ÿ“ Zhejiang Shanghai JMT-Bio Inc. ยท Tests: JMT203 Injection, JMT203 Injection A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors. NCT06487455Phase 16 sites๐Ÿ“ Changsha๐Ÿ“ Fuzhou๐Ÿ“ Hangzhou Shanghai Pharmaceuticals Holding Co., Ltd ยท Tests: SPH7485 Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118 NCT07033234Phase 11 site๐Ÿ“ Hangzhou Jiangsu Hansoh Pharmaceutical Co., Ltd. ยท Tests: HS-20118 A Phase I Study of CFT8919 in Patients With Advanced NSCLC NCT06641609Phase 11 site๐Ÿ“ Hangzhou Betta Pharmaceuticals Co., Ltd. ยท Tests: Dose-Escalation (Phase Ia) CFT8919 capsule, Dose-Expansion (Phase Ib) CFT8919 capsule, Cohort-Expansion (Phase Ic) CFT8โ€ฆ A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes NCT06945406Phase 11 site๐Ÿ“ Neuss Eli Lilly and Company ยท Tests: LY4057996 SC, LY4057996 IV, Placebo SC, Placebo IV, Degludec SC A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis NCT07533955Phase 18 sites๐Ÿ“ Sofia๐Ÿ“ Tbilisi๐Ÿ“ Berlin Jade Biosciences, Inc. ยท Tests: JADE201, Placebo CS-121 APOC3 Base Editing in FCS NCT07176923EARLY Phase 11 site๐Ÿ“ Hefei CorrectSequence Therapeutics Co., Ltd ยท Tests: CS-121 Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119 NCT06504290Phase 14 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Beijing Vigonvita Life Sciences ยท Tests: VV119 Placebo ๏ผˆin healthy adult subjects๏ผ‰, VV119 ๏ผˆin healthy adult subjects๏ผ‰, VV119(in adult patients with schizophreniโ€ฆ An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania NCT07288320Phase 211 sites๐Ÿ“ Little Rock๐Ÿ“ Cerritos๐Ÿ“ Garden Grove Neurocrine Biosciences ยท Tests: NBI-1117568, Placebo A Study of ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics in Adult Participants With Obesity NCT07291232Phase 12 sites๐Ÿ“ Anaheim๐Ÿ“ Grayslake AbbVie ยท Tests: ABBV-295, Placebo
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy